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Sensing soluble uric acid by Naip1-Nlrp3 platform
Tarcio Teodoro Braga 1,2,3, Mariana Rodrigues Davanso2,3,4, Davi Mendes 5, Tiago Antonio de Souza5,
Anderson Fernandes de Brito6, Mario Costa Cruz2, Meire Ioshie Hiyane2, Dhemerson Souza de Lima2, Vinicius Nunes2,
Juliana de Fátima Giarola7, Denio Emanuel Pires Souto7,8, Tomasz Próchnicki3, Mario Lauterbach3,
Stellee Marcela Petris Biscaia9, Rilton Alves de Freitas8, Rui Curi4,10, Alessandra Pontillo2, Eicke Latz 3,11,12 and
Niels Olsen Saraiva Camara2,13,14
Abstract
Uric acid (UA), a product of purine nucleotide degradation able to initiate an immune response, represents a
breakpoint in the evolutionary history of humans, when uricase, the enzyme required for UA cleavage, was lost.
Despite being inert in human cells, UA in its soluble form (sUA) can increase the level of interleukin-1β (IL-1β) in
murine macrophages. We, therefore, hypothesized that the recognition of sUA is achieved by the Naip1-Nlrp3
inflammasome platform. Through structural modelling predictions and transcriptome and functional analyses, we
found that murine Naip1 expression in human macrophages induces IL-1β expression, fatty acid production and an
inflammation-related response upon sUA stimulation, a process reversed by the pharmacological and genetic
inhibition of Nlrp3. Moreover, molecular interaction experiments showed that Naip1 directly recognizes sUA.
Accordingly, Naip may be the sUA receptor lost through the human evolutionary process, and a better understanding
of its recognition may lead to novel anti-hyperuricaemia therapies.
Introduction
Host responses against harmful signals are basic phy-
siological reactions of all living organisms. Innate immu-
nity pattern-recognition receptors (PRRs) were first
described as recognizing conserved structural compo-
nents of microorganisms1. The discovery of Toll-like
receptors2 led scientists to understand how the immune
system responds to nonself antigens in the context of an
infection3,4, in contrast with the previous model, in which
the immune system reacted to all nonself antigens while
being tolerant to self-antigens5,6. Based on Polly Matzin-
ger’s study stating that “the immune system is more
concerned with entities that do damage than with those
that are foreign”6, several damage-associated molecular
patterns (DAMPs) have been described. Indeed, receptors
for endogenous and exogenous signals may have evolved
simultaneously because vertebrates and pathogens have
shared eons of evolutionary time and space6. Perhaps,
PRRs have not evolved to bind to pathogens at all; in
contrast, perhaps, the pathogens evolved to attach to
PRRs and thus enhance their own survival7, a hypothesis
that would explain a puzzling feature of PRRs: each one
can attach to many different kinds of molecules.
Among several DAMPs, uric acid (UA), the product of
purine catabolism, released mainly from dying cells and
ischaemic tissues, is considered a major alarmin, espe-
cially when it is present at elevated levels and crystallized,
also known as monosodium urate (MSU)8. In rodents,
MSU activates the immune system9,10, acts as a pro-
oxidant molecule, stimulates chemotaxis and activates the
nuclear factor-κB and MAPK pathways11. Moreover,
MSU induces the release of interleukin-1β (IL-1β)
through the activation of inflammasome-dependent
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caspases10,12,13. The inflammasome is a cytosolic complex
activated when a nucleotide-binding domain (NBD/
NACHT) and leucine-rich repeat (LRR)-containing
receptor (NLR) senses PAMPs or DAMPs14. NLRs belong
to a superfamily of innate immune proteins with a very
conserved structure throughout the phylogeny, from
plants to mammals. In distinct phylogenetic groups, the
number of receptors and paralogous genes differs, possi-
bly as a consequence of host/pathogen and/or environ-
mental coevolution15. To date, it has been demonstrated
that both soluble UA (sUA)16 and MSU can induce Nlrp3
(an NLR containing a pyrin domain as its N-terminal
domain) oligomerization in mice, while the deposition of
MSU activates Nlrp3 inflammasome in humans, in the
context of gout 17.
Great apes have higher levels of UA in serum
(3.02–6.72mg/dL, corresponding to 180–400 μΜ) than
other animals (18–40 μΜ) and UA crystallization occurs, in
humans, when the level reaches 6.8mg/dL in plasma18. This
observation is compatible with the absence of uricase (or
urate oxidase) activity, the enzyme involved in purine cata-
bolism converting UA into allantoin19,20. The loss of uricase
at the divergence between great apes and other mammals
may be related to a survival advantage, as previously hypo-
thesized, due to the UA characteristics as a molecule critical
for saving energy21; however, this supposition raises a tricky
question about the role of a mammalian sensor of UA. We
hypothesize that, along with uricase loss and a consequent
elevation in UA serum levels, humans have lost the sensors
to recognize “high” levels of sUA.
Among NLRs able to induce inflammasome activation
in mice and humans, the NLRB subfamily (an NLR con-
taining a baculovirus inhibitor of apoptosis protein repeat
domain as its N-terminal domain) attracted our attention.
In mice, there are six paralogous genes, namely, Naip1–6,
and four functional receptors (Naip1, 2, 5 and 6), while in
humans, only one orthologous gene, Naip, has been
found22. Despite the differences in the amino acid content
among Naip proteins, both mice and human receptors
have been described to play role in the host defence
against pathogens23,24. Murine (m) Naip1 and Naip2 are
critical for the detection of needle and rod proteins,
respectively25–27. Naip5 is crucial for the cytosolic
recognition of flagellin28, the major protein component of
the bacterial flagellum. Similar to Naip5, human Naip
(hNaip) can bind bacterial flagellin29 and activate the
Nlrc4 inflammasome. In this scenario, Naip acts as a
ligand sensor, and Nlrc4 is critical for inflammasome
assembling and inflammasome-dependent cell death,
known as pyroptosis30. Considering the differences in
NLRB orthologous genes among different species and the
lack of endogenous ligands found for NLRB to date, in
this study, we performed transcriptome- and proteome-
wide analyses in addition to interaction investigations and
structural modelling predictions to study the sensing of
sUA by mNaip1. In addition to demonstrating that
mNaip1 expression leads to the activation in human cells
upon sUA stimulation, we found that mNaip1 directly
recognizes sUA. We then hypothesized that Naip may be
the lost receptor for UA and, in particular, for sUA.
Materials and methods
Soluble UA preparation
The medium was prewarmed (37 °C), UA (Ultrapure,
Sigma; 200 μΜ) was added, and the medium was sterilized
with 0.20 μm filters. Crystals were not detectable under
these conditions (polarizing microscopy), nor did they
develop during cell incubation.
Reagents
Ultrapure LPS (lipopolysaccharide) was obtained from
InvivoGen, and nigericin was obtained from Invitrogen.
DRAQ5 was purchased from eBioscience. Anti-GFP
monoclonal antibody (GF28R) was purchased from
Thermo Fisher Scientific. CRID3 was purchased from
R&D Systems, and allantoin, urea and palmitate were
purchased from Sigma-Aldrich. TOFA (5-(tetradecyloxy)-
2-furoic acid) (CAS 54857-86-2) was purchased from
Abcam. C75 (CAS 191282-48-1) was also obtained
from Abcam. Cerulenin (17397-89-6) was purchased from
Sigma-Aldrich, and BMS303141 (CAS 943962-47-8)
was purchased from Cayman Chemical. UK5099 CAS
56396-35-1 was obtained from Merck Millipore. Etha-
nolamine (EA), 11-mercaptoundecanoic acid (11-MUA),
N-(3 dimethylamino-propyl)-N-ethylcarbodiimide hydro-
chloride (EDC), and N-hydroxysuccinimide (NHS) were
obtained from Sigma-Aldrich Chemical (St. Louis,
MO, USA).
Macrophages obtainment
Primary murine macrophages were generated from bone
marrow. Briefly, bone marrow-derived cells were filtered
through sterile polystyrene syringes (70–100 µm) and divi-
ded among 10 Petri dishes (100 × 20mm2; BD, Franklin
Lakes, USA) supplemented with murine macrophage CSF
(20 ng/mL; R&D Systems, Minneapolis, MN, USA) diluted
in high-glucose Dulbecco’s modified Eagle’s medium
(Invitrogen, USA) in the presence of 5% foetal bovine serum
for 7 days. All procedures with mice were approved by the
local ethics committees at the University of São Paulo
(Document 45/2009). All experiments were performed in
accordance with relevant guidelines and regulations.
Human and rhesus macaque (Macaca mulatta) mac-
rophages were generated from circulating monocytes. A
centrifugation gradient was used to obtain human and
monkey peripheral blood mononuclear cells in Ficoll-
Paque (Dominique Dutscher). Subsequently, the periph-
eral blood mononuclear cells were centrifuged in 51%
Braga et al. Cell Death and Disease          (2021) 12:158 Page 2 of 14
Official journal of the Cell Death Differentiation Association
phosphate-buffered saline-diluted Percoll (GE Healthcare
Life Sciences), and the monocytes (>70% purity) were
allowed to adhere to six-well plates for 4 h. After removal
of nonadherent cells by washing the plates, the monocytes
were differentiated into macrophages in RPMI medium
(Gibco, Grand Island, NY, USA) supplemented with 10%
foetal calf serum (Gibco) plus antibiotics and antimycotics
(100 U/mL penicillin, 100 g/mL streptomycin and 25 g/
mL amphotericin; Gibco) in the presence of human
macrophage CSF (25 ng/mL; R&D Systems, Minneapolis,
MN, USA) for 5 days. All procedures with rhesus maca-
ques were approved by the Ethics Committee on Animal
Use of the Butantan Institute (CEUAIB) (number
9376040717). Leucocyte concentrates were obtained after
plasmapheresis at the Blood Bank Service of the “Hospital
das Clinicas” in Sao Paulo (SP, Brazil), and they were used
for peripheral blood monocyte isolation. All volunteers
signed informed consent in compliance with the respec-
tive Institutional Ethics Committee. We performed power
and sample size calculations to determine how large the
sample needed to be to obtain 90% power when com-
paring a categorical variable among groups. Experiments
were performed in duplicate or triplicate, and at least two
independent tests were performed for each assay. The
data are described in terms of the means and s.e.m. unless
specified in the figure legend.
Viral transduction
Plasmids for GFP-tagged mNaip1 (#60200), Naip5
(#60205), Naip6 (#60202), Nlrc4 (#60199) and empty
vector (#60206) were purchased from Addgene (Water-
town, MA, USA). Transformed bacteria with the GFP-
tagged mNaip2 (#60201) plasmid were not able to grow.
The plasmid was additionally modified by adding a “self-
cleaving” 2A (T2A) sequence between Naip1 and the
colour-tagged sequences with standard cloning techni-
ques. Briefly, THP1 cells (ATCC, TIB202) were retro-
virally transduced with constructs for the indicated
plasmids. After retroviral transduction, the cells were
cytometrically sorted with cells with similar levels of GFP
or turquoise expression. Nlrp3-deficient (Nlrp3−/−)
macrophages have been previously described31, and Nlrp3
deletion from THP1 cells was performed according to the
procedure described by Schmid-Burgk et al.32.
Cytokine profile
Cell lysates were maintained in RIPA buffer with pro-
tease inhibitors at −80 °C until dosing. IL-1β protein was
measured using IL-1β (R&D Systems, Minneapolis, MN,
USA) according to the manufacturer’s instructions.
RNA extraction, library construction and sequencing
Total RNA was extracted from GFP-sorted THP1 cells
containing the lentiviral vector NAIP1 (n= 6) or the
empty vector GFP+ control cells (n= 6) using TRIzol
reagent according to the manufacturer’s instructions
(Thermo Fisher Scientific, Waltham, MA, USA). The
integrity of the total RNA was checked using a Bioana-
lyzer 2100 (Agilent Technologies, CA, USA) with an RNA
Nano 6000 kit. RNA purity and quantity were measured
using a NanoDrop 1000 spectrophotometer and Qubit
RNA HS fluorescence kit (Thermo Fisher), respectively.
The total RNA concentration of each sample (n= 12) was
adjusted to 1 µg and used for poly(A) messenger RNA
(mRNA) enrichment and strand-specific RNA-Seq (RNA
sequencing) library preparation with a TruSeq Stranded
mRNA kit (Illumina, San Diego, CA, USA). Quality con-
trol of the prepared libraries was performed using an
Agilent Bioanalyzer DNA 1000 kit and Qubit DNA HS
fluorescence kit. The libraries were pooled and then
sequenced at CEFAP-USP (Sao Paulo, Brazil) on an Illu-
mina NextSeq platform in 75-bp paired-end mode using a
high output kit.
RNA-Seq data analysis
Before read mapping, clean reads were selected after
preprocessing with Trimmomatic33 to remove adapter and
poly(N) sequences. After cleaning, the quality of reads was
checked by the FastQC tool and then aligned to the human
genome (GRCh38/hg38) using the HISAT2 aligner (V2-
2.0.0)34 considering strandness. The overall mapping quality
and uniformity of the read coverage on exons were checked
by the RSeQC tool to ensure good RNA integrity and
reproducible RNA-Seq. The StringTie (v.1.3.4)35 and Ball-
gown36 algorithms were applied to identify significantly
differentially expressed genes (q value <0.05) based on the
“new Tuxedo” package37. Gene set enrichment analyses
were performed using the Enrichr tool and GAGE package
to identify upregulated (fold change (FC) > 1 and q value
< 0.05) and downregulated genes (FC < 1 and q value
< 0.05). High-throughput sequence data were uploaded as
supplemental material.
Proteomics analysis
Protein solutions were quantified by fluorometry using a
Qubit® protein assay kit. From these solutions, an
equivalent aliquot of 50 μg of protein was transferred to
0.5 mL tubes and dried. The protein pellets were sus-
pended in 6M urea in aqueous solution (25 μL). The same
volume of reducing reagent plus 10 mM dithiothreitol was
added, and the samples were reduced for 60 min at room
temperature. Subsequently, 50 μL of an alkylation solu-
tion, 100 mM iodoacetamide, was added, and the samples
were alkylated for another 60min at 54 °C in the dark.
Next, 1 M dithiothreitol (1 μL) was added and allowed to
react with the remaining iodoacetamide. Finally, 100 μL of
ice-cold trypsin solution at a 1:50 (trypsin:protein) ratio
was added to the samples, followed by incubation for 16 h
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at 37 °C. Following digestion, the reaction was stopped by
adding 10% formic acid (5 μL). The samples were then
desalted using ZipTips® and maintained at −20 °C until
analysis.
Peptides were analysed by online nanoflow LC-MS (liquid
chromatography-mass spectrometry) in an EASY-nLC II
system (Thermo Scientific) connected to an LTQ-Orbitrap
Velos instrument (Thermo Scientific) and a Proxeon
nanoelectrospray ion source. The peptides were separated
on an analytical EASY column (10 cm, ID 75 μm, 3 μm, C18;
Thermo Scientific) previously trapped in a precolumn EASY
column (2 cm, ID100 μm, 5 μm, C18; Thermo Scientific).
Tryptic digested peptides were separated using a 60min
linear gradient of 0–60% buffer B (acetonitrile in 0.1% formic
acid) at a 300 nL/min flow rate. The LTQ-Orbitrap Velos
mass spectrometer was operated in positive ion mode using
DDA (data-dependent acquisition) mode. Full mass spec-
trometric (MS) scans were performed with 60,000 resolu-
tion, and them/z range for the MS scans was 400–1200. The
minimum signal threshold was 15,000 counts, and for
dynamic exclusion, it was considered a one repeat count
with a duration of 30 s. To discriminate the charge state of
the peptides, charge state screening was enabled, and ions
with an unassigned charge state or singly charged ions were
rejected.
The MS/MS spectra from each LC-MS/MS run were
compared against five different databases with two dis-
tinct search engines, an in-house program and Proteome
Discoverer 1.4 software (Thermo, USA). The search cri-
teria were as follows: full tryptic specificity was required,
two missed cleavages were allowed, carbamidomethyla-
tion (C) was set as the fixed modification, oxidation (M)
was set as the variable modification, precursor ion mass
tolerance was set at 10 p.p.m. for all the MS spectra
acquired with the Orbitrap mass analyser, and the frag-
ment ion mass tolerance was set at 0.6 Da for all the
MS2 spectra acquired. All covariates were log-
transformed before statistical analysis was performed.
All analyses were performed using STRING software and
UniProt for protein–protein interactions, identification,
and statistics. P ≤ 0.05 was considered significant.
Oxygen consumption rates
An hour before the oxygen consumption measure-
ments, the cell medium was replaced by assay medium
(2 mM glucose, 0.8 mM Mg2+, 1.8 mM Ca2+, 143 mM
NaCl, 5.4 mM KCl, 0.91 mM NaH2PO4 and 15mg/mL
Phenol red) and incubated for 60min at 37 °C (no CO2)
before loading into a Seahorse Bioscience XF96 extra-
cellular analyser. During the 60-min period, the ports of
the cartridge containing the oxygen probes were loaded
with the compounds to be injected during the assay
(75 μL/port), and the cartridge was calibrated. Basal
respiration was recorded for 30min at 4-min intervals
until system stabilization. CCCP (carbonyl cyanide p-tri-
fluoromethoxyphenylhydrazone) was used at a final con-
centration of 5 mM and injected with sodium pyruvate
(Sigma) at a final concentration of 5 mM. Oligomycin and
antimycin A were used at final concentrations of 1 and
10 μg/mL, respectively. Rotenone was used at a con-
centration of 1 μM. All respiratory modulators were used
at ideal concentrations titrated during preliminary
experiments (not shown). A typical oxygen consumption
ratio (OCR) chart is displayed, where OCR represents the
percentage of basal respiration.
Western blotting
Proteins derived from cell lysates were separated on
sodium dodecyl sulfate-polyacrylamide gel electrophor-
esis gels (4–12%) (Novex, Invitrogen) with 2-(N-mor-
pholino) ethanesulfonic acid buffer (Novex, Invitrogen) at
150 V from 60 to 90min. The proteins were transferred
onto polyvinylidene difluoride membranes (Millipore,
Temecula, CA, USA), which had been pretreated for
1–2min with methanol, at 32 V for 90min in buffer
containing 10% Tris-glycine and 15% methanol. The
membranes were blocked with 3% bovine serum albumin
(BSA) containing Tris buffer in saline solution (TBS) for
60min. After blocking, the membranes were incubated
with specific primary antibodies in TBS containing 3%
BSA and 0.1% Tween-20 overnight. The following pri-
mary antibodies were used: goat anti-mouse Naip1 (sc-
11067, 1:200; Santa Cruz Biotechnology, Santa Cruz, CA,
USA), rabbit anti-mouse NLRP3 (mAb #15101, 1:1000;
Cell Signalling Technology, Danvers, MA, USA), anti-
β-actin mouse (1:1000, Li-COR Bioscience, Lincoln, NE,
USA) and anti-IL-1β from an R&D ELISA kit as a
detection antibody (1:1000). The membranes were
washed and incubated with secondary antibodies (IRDye
800CW or IrDye 680RD, LI-COR Biosciences, 1:20,000)
for 60min. After washing, the stained cells were visualized
on an Odyssey imaging system. The staining intensity was
quantified using the Fiji/ImageJ software.
Confocal imaging
Confocal laser scanning microscopy was performed
with a Leica TCS SP5 SMD confocal system (Leica
Microsystems). The images were captured using a single z
step, and the emitted fluorescence was detected by scan-
ned detectors at 490–520 and 575–605 nm and emission
filters. Predefined settings for the laser power and detector
gain were used for all experiments. Microphotographs
were analysed using LAS AF version 2.2.1 (Leica Micro-
systems) or Volocity 6.01 software.
Quartz crystal microbalance (QCM)
The interaction of the Naip1 protein with sUA was
analysed in a QCM device (Stanford Research Systems
Braga et al. Cell Death and Disease          (2021) 12:158 Page 4 of 14
Official journal of the Cell Death Differentiation Association
(SRS)). A plasmid carrying GFP-tagged Naip1 was virally
transduced into THP1 cells, and cell lysates were used to
bind the Naip1 protein to anti-GFP previously immobi-
lized onto gold quartz crystals (SRS, 5MHz). Prior to
antibody immobilization, the gold crystals were immersed
in piranha solution 1:3H2O2/H2SO4 for 15min, washed
twice with absolute ethanol for 5 min, washed three times
with ultrapure water for 5 min and dried with a gentle
flow of nitrogen. Then, the gold crystals were incubated
with EDC (100mmol/L) and NHS (150mmol/L), and
finally, 200 μL of 20 μg/mL anti-GFP (MA5-15256,
Thermo Fisher Scientific) diluted in ultrapure water was
deposited over each crystal for 16 h at 4 °C in a humid
chamber. The crystals were rinsed in three sequential
ultrapure water baths, dried at 22 °C and blocked with 1%
BSA solution for 1 h at 37 °C. After incubation, all sample
chips were washed and dried as described above. Then,
200 μL of cell lysate was deposited onto the crystals for
16 h at 4 °C in a humid chamber. The crystals were placed
in a QCM flow chamber apparatus connected to a syringe
pump with a 100 μL/min flow rate (KD Scientific). An
initial hydration step with 500 μL of ultrapure water was
performed, and 500 μL of each sUA solution sample (12.5,
25, 50, 100 and 200 μΜ) was injected in individual
experiments. Each experiment was performed in tripli-
cate. The results are expressed as the average value.
Surface plasmon resonance (SPR)-based immunosensor
development
An Autolab Sprit instrument (Eco Chemie B.V., The
Netherlands), which reveals the phenomenon of atte-
nuated total internal reflection (Kretschmann configura-
tion) in operation mode38, was employed for the SPR
analysis. This SPR instrument was equipped with a glass
prism (BK7), a planar gold SPR sensor chip, and two
measurement channels (channels 1 and 2). For the mea-
surements, a laser diode with a wavelength fixed at
670 nm and a photodiode detector was employed. In
terms of functionality, changes near the metal/environ-
ment interface promote a change in the resonance con-
ditions of the system, resulting in a shift in the θSPR. In
this sense, SPR techniques enable information on bio-
molecular interactions to be obtained in real time.
The experiments were performed as demonstrated by
Souto et al.39. Prior to gold surface functionalization, the
SPR sensor chip was cleaned in piranha solution (1:3
mixture of 30% H2O2 to concentrated H2SO4) for ~1min,
followed by immersion of the substrate in acetone (5min)
and then in isopropyl alcohol (5min). Next, the SPR
sensor chip was washed with deionized water and dried
under a pure N2(g) flow. The functionalization of the gold
surface was performed through the formation of a self-
assembled monolayer (SAM), which was obtained after a
24 h incubation in an ethanol solution consisting of 11-
MUA (1.0 mmol/L). After the formation of the film, the
gold surface (11-MUA/Au) was copiously washed with
ethanol and water and dried under an N2(g) flow. All the
steps described above were performed ex situ. In the next
step, the functionalized SPR sensor chip was immediately
inserted into the SPR instrument, and the measurements
were obtained in real time. The terminal carboxyl groups
of 11-MUA were activated in a PBS (phosphate-buffered
saline) buffer solution (10mmol/L at pH 7.4) containing
EDC (100mmol/L) and NHS (150mmol/L) for ~10min to
allow the formation of NHS-ester groups. This strategy
was used to allow covalent binding of anti-GFP (20 μg/mL)
onto the gold (11-MUA/Au) of the SAM. Next, successive
aliquots of the buffer solution were added to remove the
excess molecules on the surface. Then, the immobilization
of the anti-GFP was monitored via the SPR technique for
~45min. This step was followed by a washing step using
the successive addition of buffer solution. To prevent
nonspecific binding, after the immobilization of anti-GFP
onto the 11-MUA/Au surface (SAM/Au), the unbound
reactive ester groups were deactivated by a PBS buffer
solution containing EA (1.0 mol/L at pH 8.5) for ~5min.
Successive additions of the buffer solution then removed
the excess unbound EA molecules. After successfully
characterizing the immobilization and blocking steps, the
interaction between the anti-GFP and Naip1 protein
(GFP-tagged) was evaluated. Cell lysates derived from
GFP-tagged THP1 cells expressing mNaip1 were used to
immobilize Naip1. After characterizing the interaction
between anti-GFP and Naip1 protein, an aqueous solution
of sUA was added to evaluate the interaction of sUA with
Naip1 protein. As a control for this assay, the interaction
of palmitate with the Naip1 protein was also evaluated.
Protein structure analysis
Homology models were obtained using MODELLER
v.9.1840 with the 4KXF structure as a template41. To fix
residues with incompatible torsion angles, the target
proteins were repaired using RepairPDB42, and Chi-
maera43 was used to add hydrogen atoms and charges
where appropriate. Surface electrostatic potentials were
calculated using the AMBER force field implemented for
APBS44 and input files that were converted with the
PDB2PQR package45. For each NAIP structure, blind
docking was performed using SwissDock46 with UA in its
ionized form (urate) as a ligand (ZINC AC: 2041003).
During docking, the surface of both proteins was scanned
for putative binding pockets with >250 iterations. Several
low-energy ligand clusters with similar binding modes
(poses) were found. All poses with ΔG <−6 kcal/mol
were considered in further analyses, and those showing
the lowest energies were selected as the best repre-
sentatives of the binding between urate and both human
and mNaip.
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Statistics
Experiments were performed in duplicate or triplicate,
and at least two independent tests were performed for
each assay. The data are described in terms of the means
and s.e.m. unless specified in the figure legend. Differ-
ences between groups were compared using analysis of
variance (with Tukey’s post-test) and Student’s t test.
Significant differences were regarded as p < 0.05, p < 0.01
or p < 0.001, according to the figure. All statistical analyses
were performed using GraphPad Prism 6.01 (La Jolla, CA,
USA). Animals were allocated into groups by similar age
and sex. Cells were allocated into groups and treated with
plasmids carrying different constructs as specified in the
figure legends. In addition, cells were treated with dif-
ferent compounds to trigger or inhibit an inflammasome-
mediated response, as stated in the figure legends. No
masking or blinding was used for group allocations.
Results
Naip1 is involved in the sUA response
To assess the difference in serum basal levels of UA
among species, we initially measured the UA levels of
unrelated healthy adult human donors (n= 5), C57Bl/6
mice (n= 5), and old-world monkeys (rhesus macaques; n
= 5). As expected, the human’s samples exhibited an average
blood UA concentration of 295 μΜ, 4- and 7-fold greater
than the mice and rhesus macaques UA levels, respectively
(Fig. 1A). Then, we stimulated murine LPS-primed BMDMs
and human and rhesus LPS-primed monocyte-derived
macrophages with 200 μΜ sUA. The human cells did not
produce IL-1β after sUA stimulus when compared to the
level produced by LPS-primed cells (Fig. 1B). On the other
hand, murine BMDMs showed increased IL-1β production
after sUA stimulation compared to the BMDMs primed
with LPS (Fig. 1C). Surprisingly, despite 200 μΜ being
supraphysiological for rhesus macaques, the macrophages of
these primates did not show increased IL-1β production
after the sUA stimulus (Fig. 1D). Ischaemic tissues con-
sistently overproduce UA that triggers immune cell func-
tions47. Both sUA stimulation and hypoxic conditions led to
increased Naip1 mRNA expression levels in the mouse
BMDMs (a 5- and 15-fold increase, respectively) but did not
affect Naip5 (Sup. Fig. 1A, B). In addition, BMDMs derived
from Naip1−/− and ΔNaip−/− mice did not show increased
Fig. 1 Human cells do not produce IL-1β upon sUA+ LPS stimulus, unless they express mNaip1. A Uric acid levels measured in the serum of
humans, mice and rhesus monkeys. IL-1β Elisa of B monocyte-derived macrophages collected from healthy people, C murine bone marrow-derived
macrophages and D monocyte-derived macrophages collected from rhesus monkeys, all stimulated under different conditions. In B–D, LPS was
added for 1 h at 100 ng/mL and the media were posteriorly changed. MSU (100 μg/mL) and sUA (200 μΜ) were added for 6 h. Each coloured dot
represents a different individual. E IL-1β Elisa of BMDM derived from Naip1−/−, Naip2−/−, Naip5−/−, ΔNaip−/− and Nlrc4−/− mice under different
stimulus. F IL-1β Elisa of human THP1 cells virally transduced with plasmids carrying Naip1, Naip5, Naip6, Nlrc4 and empty vector using lentivirus
constructs and posteriorly stimulated under different conditions. In E, F, LPS was added for 1 h at 100 ng/mL and the media were posteriorly
changed. sUA (200 μΜ) was added for 6 h and nigericin (10 μΜ) was added for 90 min. In A, n= 5 for each analysed species. Triangle refers to
human’s sample, Circle refers to murine’s sample and Square refers to rhesus’ sample. In B, C, we collected cells from eight different individuals; in D,
we collected cells from seven different individuals. In E, F, data are plotted as the median of a triplicate of three to four independent experiments. *p
< 0.05 and ***p < 0.001; n.s. not significant.
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IL-1β production upon sUA stimulation compared to the
amount produced by the LPS-primed macrophages (Fig. 1E).
On the other hand, Naip2−/− and Naip5−/− cells behaved as
wild-type macrophages, and despite the variation within
groups, there were no differences in IL-1β production
between the BMDMs from Nlrc4−/− animals after sUA
stimulus and the LPS-primed cells from Nlrc4−/− mice (Fig.
1E). To confirm the role of the mNaip platform in the sUA
response, we virally transduced human THP1 cells with
mNaip1, mNaip5, mNaip6, mNlrc4, and an empty backbone
vector. Our data demonstrate that phorbol myristate acetate
(PMA)-activated and LPS-primed THP1 cells produced IL-
1β after sUA stimulus only after mNaip1 transduction but
not mNaip5, mNaip6, mNlrc4 or the control empty vector
(Fig. 1F). Such data point to mNaip1 as a target gene
involved in the sUA response.
IL-1β production in human cells is dependent on Nlrp3 and
mNaip1
The Naip1-carrying plasmid was modified by adding a
“self-cleaving” 2A (T2A) sequence between the Naip1
gene and the colour-tagged sequences. In this setup, the
overexpressed Naip1 protein is not colour-tagged, which
may lead to some data being misinterpreted. Initially, the
ability of PMA-activated, LPS-primed and mNaip1-
expressing THP1 cells to produce IL-1β upon exposure
to UA degradation products, that is, allantoin, urea and
ammonium were investigated. None of the products was
able to induce IL-1β production, in contrast to the effect
of sUA (Fig. 2A). The role of Nlrp3 in sUA sensing, as
previously stated16, was further investigated. To this end,
we initially evaluated IL-1β production upon sUA sti-
mulus of THP1 cells virally transduced with either
mNaip1 or the empty backbone stimulated in the pre-
sence or absence of an Nlrp3 inhibitor, CRID3 (1 μΜ)48.
The IL-1β levels were reduced in the cells pretreated with
CRID3 (Fig. 2B). IL-1β production was also evaluated in
THP1 cells after Nlrp3 gene deletion by CRISPR-Cas9. It
was confirmed that IL-1β production is dependent on
Nlrp3 activation (Fig. 2B–D), because Nlrp3-deleted cells
exhibited decreased levels of IL-1β upon sUA stimulation
(Fig. 2C, D). To investigate the interaction between Naip1
Fig. 2 Naip1 and NLRP3 are required for LPS-primed THP1 cells to produce IL-1β upon sUA. A IL-1β Elisa of mNaip1-transduced LPS-primed
THP1 cells, stimulated with the products of uric acid degradation allantoin, urea and ammonium, the control non-treated cells (Medium) and LPS-
primed treated with nigericin. B IL-1β Elisa of THP1 cells virally transduced with an empty backbone or with mNaip1 after 1 h pretreatment with LPS
(1 µg/mL), 6 h treatment with sUA (200 μM), 30 min treatment with nigericin or control non-treated cells (Medium). Some groups were pretreated
with the Nlrp3 inhibitor CRID3 at 1 μΜ 30 min before LPS priming. C IL-1β Elisa of WT THP1 and Nlrp3−/− THP1 cells virally transduced with an empty
backbone or with mNaip1 after 1 h pretreatment with LPS, 6 h treatment with sUA, 30 min treatment with nigericin or control non-treated cells
(Medium). D IL-1β and Nlrp3 western blotting images of WT THP1 and Nlrp3−/− THP1 cells virally transduced with an empty backbone or with
mNaip1 in control non-treated condition (Medium), or LPS-primed and treated with sUA for 6 h, or with nigericin for 30 min. In A blue bars represent
the levels of produced IL1beta (pg/mL), analysed by Elisa. In D, data are representative of three independent experiments. All experiments were
performed three different times and data are plotted as a median of a triplicate. **p < 0.01, and ***p < 0.001.
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and Nlrp3, immunoprecipitation assays with THP1 cell
lysates using both Nlrp3 and Naip1 as targets were per-
formed (Sup. Fig. 2). However, the targets were found
only in the whole-cell lysates, not the immunoprecipitates,
suggesting that Nlrp3 and Naip1 may not directly interact.
Altogether, these data indicate that the observed IL-1β
production followed by sUA stimulation requires both
Naip1 and Nlrp3 inflammasome platforms.
Naip1 triggers enhanced immune responses and altered
cellular metabolite levels in response to sUA
To clarify the mNaip1 influence on sUA sensing, RNA-
Seq analysis of mNaip1- and backbone-transduced
THP1 cells was performed. The presence of Naip1
affects gene transcription, which was evident when the
gene expression differences are presented in a volcano
plot (Sup. Fig. 3A). The unsupervised hierarchical clus-
tering of 8000 genes (Sup. Table 1) and the top 20 most
downregulated and most upregulated genes, as deter-
mined by the means of the centred logarithm of FPKM
(fragments per kilobase of exon model per million reads
mapped) values in the six replicates of each experimental
group, demonstrated that sUA-stimulated macrophages
globally reprogramme transcriptional responses after
mNaip1 is expressed (Sup. Fig. 3B). A detailed inspection
of the most highly differentially expressed genes revealed
that ccl2, pik3cd, nck2, tab1 and fgfr1 were expressed
more strongly in mNaip1-expressing GFP-tagged cells
stimulated with sUA than in GFP-transduced (control)
cells stimulated identically (Sup. Fig. 3C). The functional
annotation enrichment analyses of KEGG and PANTHER
pathways demonstrated that PMA-activated and LPS-
primed THP1 cells expressing mNaip1 led to a shift
towards increased inflammation-, cancer- and infection-
related signalling pathways (Sup. Fig. 3D). The enrich-
ment term analysis using genes that were upregulated in
the mNaip1-expressing macrophages revealed a more
detailed vision of the KEGG pathway enrichment network
(Sup. Fig. 3E). Together, these analyses showed that
upregulated genes were associated with processes
involved in cytoskeleton regulation, adherent junctions,
proteoglycans in cancer, bacterial infection and invasion
and the immune response (Sup. Fig. 3E). These data
demonstrate that mNaip1 triggers enhanced immune
responses after sensing sUA.
In addition to gene expression profiling, we performed a
proteomic analysis to identify differentially expressed
proteins following sUA stimulation in both control (GFP-
transduced) and mNaip1-expressing LPS-primed
THP1 cells, and here, we highlight the proteins found only
upon exposure to the sUA stimulus in orange and the
proteins expressed only under LPS-primed conditions in
yellow (Sup. Fig. 4A, Sup. Table 02 and Sup. Table 03).
Moreover, the two different cell groups under sUA
stimulus were compared (Sup. Fig. 4B). Among the 44
proteins expressed only in mNaip1-expressing cells and
not expressed in control cells, we highlighted 30 proteins,
including some related to the immune response, such as
thymopoietin (A0A024RBH7), CD99 (A8MQT7), stress-
associated endoplasmic reticulum protein (Q9Y6X1) and
lysosome-associated membrane glycoprotein 2 (H0YCG2)
(Sup. Fig. 4B). In addition, the upregulation of mito-
chondrial citrate synthase (F8VRP1), amino acid trans-
porter (M0R106), mitochondrial glutamate carrier 1
(Q9H936), inorganic pyrophosphatase (Q15181), α-N-
acetylgalactosaminidase (P17050), phosphoinositide
phospholipase C (B7Z5V4) and acyl-CoA dehydrogenase
isoform 4 (A0A0S2Z3A5), which are all associated with
cellular metabolism, were observed (Sup. Fig. 4B). We
highlight 60 proteins among 342 that were expressed only
in the GFP+ control cells, including transforming growth
factor-beta-induced protein (H0Y8L3), solute carrier
family 25-member 4 isoform 3 (A0A0S2Z359) and
vimentin (B0YJC4) (Sup. Fig. 4B and Sup. Table 04).
Notably, 84% of the analysed proteins assessed in the
comparison between the two different cell groups sti-
mulated by sUA were detected in the RNA-Seq data.
However, only 2.8% of the expressed proteins corre-
sponded to differentially expressed genes (data not
shown). We built a STRING network of only the proteins
expressed in mNaip1-expressing cells but not in GFP+
control cells, both stimulated by sUA (Sup. Fig. 4C), and
the results showed that they were involved in upregulated
metabolism-related pathways, especially pathways related
to lipid metabolism. These data demonstrate that, in
addition to the immune response, mNaip1 is associated
with altered cellular metabolite content in LPS-primed
macrophages stimulated with sUA.
Naip1 activation may be potentiated after the elevation of
the cellular content of total lipids
UA is also described as increasing the amount of tri-
glycerides accumulated in hepatic cells49. Hence, we
investigated lipid drop formation in LPS-primed
THP1 cells stimulated with sUA. An increase in the cel-
lular content of lipids was observed after sUA stimulation
but in a mNaip1-independent manner (Fig. 3A, B).
Alterations in metabolite content also lead to changes in
mitochondrial activity; once these plastic organelles sense
cellular metabolites, oxygen and nutrients, they play
central roles as sources of energy and ROS50. Changes in
mitochondrial membrane potential in live cells upon sUA
stimulation were therefore measured (Fig. 3C, D). Despite
no differences in mitochondrial area stained with Mito-
Tracker, a reduced mitochondrial membrane potential
was observed, as indicated by failure to load the positively
charged mitochondrial indicator TMRE in mNaip1-
expressing cells stimulated with sUA compared to that
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in the LPS-primed cells (Fig. 3C, D). We next measured
the OCR of THP1 cells virally transduced with an empty
backbone or mNaip1, both LPS-primed, treated or not
with sUA. sUA increased the OCR but in a Naip1-
independent manner. The mitochondrial pyruvate carrier
inhibitor UK5099 (100 μΜ) was used to evaluate ATP
consumption derived from fatty acids indirectly. Here, the
OCR increase was also reversed by UK5099 pretreatment
Fig. 3 Naip1 activation upon sUA stimulus may be potentiated after the elevation of the cellular content of neutral lipid. A Representative
images of THP1 cells transduced with an empty backbone or mNaip1 at LPS-primed condition or LPS-primed and stimulated with sUA for 6 h. The
membrane is in red and lipid droplets are stained for LD540, in green. B Quantification of lipid droplets per cell. C Representative images of empty
backbone- and mNaip1-transduced cells primed with LPS or LPS-primed and sUA-stimulated stained with MitoTracker (red), tetramethylrhodamine
ethyl ester (TMRE) (green) and DAPI (blue). The bars in each image represent 20 μm D TMRE quantification, indicating polarized mitochondria of the
experiments in panel (C). E IL-1β Elisa of empty backbone- (red bars) and mNaip1- (blue bars) transduced cells, both at non-stimulated (Medium)
condition or LPS-primed and stimulated for 6 h with sUA, citrate or palmitate. F Schematic representation of the TCA cycle and the fatty acid
synthesis pathway given emphasis to the inhibitors and stimulus used in panel (J). G IL-1β Elisa of mNaip1-transduced and LPS-primed cells,
stimulated for 6 h with sUA (200 μΜ), citrate (5 mΜ) or palmitate (100 μΜ), in the presence or absence of ATP citrate lyase inhibitor (BMS303141 at
25 μΜ), acetyl-CoA carboxylase inhibitor (TOFA at 10 μg/mL), or fatty acid synthase inhibitors (C75 at 50 μΜ or cerulenin at 5 μg/mL). In A, B, data are
representative of three independent experiments and n= 12. In D, data are plotted as a median of ten different micrography fields of three
independent experiments. In E, F, the experiments were performed three different times and n= 3. **p < 0.01 and ***p < 0.001.
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in both cell types (Sup. Fig. 5A, B). Altogether, these data
indicate that upon sUA stimulation, mNaip1 expression
alters the cellular fatty acid content and reduces the
number of active mitochondria in cells.
We next investigated whether the elevation of fatty acid
synthesis could trigger IL-1β production. For this assess-
ment, the levels of IL-1β in the supernatant of the LPS-
primed cells virally transduced with an empty backbone or
mNaip1 were measured after 6 h of incubation with citrate51
and palmitate. Despite significant production of IL-1β in the
empty backbone-transduced cells upon both citrate (5mΜ)
or palmitate (100 μΜ) stimulation, compared to the LPS-
primed cells, the mNaip1-expressing cells produced even
higher levels of IL-1β than the empty backbone-transduced
cells regardless of the stimuli (Fig. 3E). Moreover, the LPS-
primed mNaip1-expressing cells were stimulated with sUA
or citrate in the presence of the acetyl-CoA carboxylase-α
inhibitor TOFA (10 μg/mL), the phospho-ACLy inhibitor
BMS30314152 (25 μΜ) or the fatty acid synthase inhibitors
C75 (50 μΜ) and cerulenin (5 μg/mL)53, as shown in sche-
matic Fig. 3F. All these inhibitors, except TOFA, led to
decreased levels of IL-1β (Fig. 3G) upon sUA or citrate sti-
mulation. Altogether, our data suggest that sUA leads to
fatty acid synthesis independent of mNaip1 expression.
Saturated fatty acids promote Nlrp3 inflammasome activa-
tion54, especially palmitate55. In addition, we found that
citrate- and palmitate-mediated IL-1β production is poten-
tiated in the presence of Naip1.
Naip1 directly recognizes sUA
In a study investigating the role of different lipids in
macrophage lipidomics, palmitate presented the most pro-
nounced effects56. To investigate whether mNaip1 directly
senses sUA and/or palmitate, we performed a QCM with
dissipation (QCM-D) analysis. After an initial immobilizing
step with anti-GFP, we incubated the sUA solution sample
of increasing concentrations (12.5, 25, 50, 100 and 200 μΜ).
It was observed that mNaip1 directly interacts with sUA. As
sUA adsorption capacity was reached, the QCM-D fre-
quency changed maximally, even at the lowest studied
concentration (Fig. 4A), indicating saturation at lower con-
centrations and an increase in the mass adsorbed per area.
Also, we compared the interaction of mNaip1 stimulated
with sUA and with palmitate in real time with an SPR
immunosensor. With SPR-based biosensor technology,
mNaip1 is tethered to the surface of a previously functio-
nalized SPR sensor chip, and the possible ligands are
introduced in solution, as illustrated in the scheme of Fig.
4B. The SPR curves (sensorgram) obtained in real time for
all steps involved in the evaluation of the interactions
between sUA and mNaip1 protein (purple curve) and
between palmitate and the mNaip1 protein (green curve)
are shown in Fig. 4B. Notably, a significant variation in
response (ΔθSPR) was obtained after the addition of sUA
(2 µΜ), which characterizes the interaction between sUA
and the mNaip1 protein. In this phase of the study,
higher concentrations of sUA (12.5–200 µΜ) were also
accompanied by significant responses (data not shown). In
turn, the addition of palmitate at a concentration of 2 µΜ
(green curve) and at higher concentrations (12.5–200 µΜ—
data not shown) did not trigger a notable response.
These results suggest that sUA directly binds to the
mNaip1 protein.
Fig. 4 QCM monitoring and SPR sensorgram evidencing all steps
involved in the detection of the interaction between sUA and
Naip1 protein. A QCM responses over time within sUA injection after
Naip1 immobilization upon anti-GFP adsorption on the gold quartz
crystals surface at 37 °C. The arrows indicate sample injection. B Schematic
representation of the constructed SPR sensor chip (in the box). Sequential
addition of compounds into the system: addition of the buffer solution
(PBS, 10mmol/L at pH 7.4); mixture consisting of EDC (150mmol/L) and
NHS (150mmol/L); PBS; immobilization of anti-GFP (10 µg/mL); PBS;
addition of ethanolamine (EA); addition of cell lysates containing Naip1
protein (2 µg/mol/L). It is possible to observe a very intensive response for
the interaction of the Naip1 protein with anti-GFP; PBS; addition of pure
H2O; addition of sUA (2 µmol/L, purple line) and palmitate (2 µmol/L,
green line). It is possible to observe the significant variation of the SPR
angle (ΔθSPR) due to the interaction between sUA and Naip protein. In A,
B, data are representative of three independent experiments.
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hNaip and mNaip1 may respond differently to UA
As previously studied, for inflammasomes to be
formed, NLR proteins, such as Naip, must recognize the
ligands to be released from their autoinhibited state to
finally trigger the oligomerization of NLRCs and
assemble inflammasome complexes57,58. After model-
ling the structures of mNaip1 and hNaip in their inac-
tive forms, we observed important differences in their
surface electrostatic properties, which may directly
interfere with their ability to recognize specific ligands.
By performing molecular docking, we investigated
regions of possible binding of sUA onto the solvent-
accessible surface of both Naip proteins (Fig. 5). More
than 250 iterations were performed for each target.
Given the ligand-binding geometry of each interaction,
the docking results were summarized as clusters con-
taining one or more ligands with similar binding poses.
Figure 5 displays only clusters with a Gibbs free energy
ΔG <−6 kcal/mol, with the binding pose with lowest
energy (i.e., highest affinity/stability) being highlighted
in both targets. As expected, due to their structural
differences, the regions where sUA binds in both Naip
proteins are mostly discordant. While the predicted
binding region of sUA in mNaip1 lies in the NBD
domain (ΔG=−7.92 kcal/mol) (Fig. 5A), for hNaip, the
ligand most likely exhibits higher affinity for the LRR
domain (ΔG=−8.00 kcal/mol) (Fig. 5D).
Considering our experimental results and the homology
modelling and molecular docking, we hypothesize that the
surface electrostatics of mNaip1 enables this protein to
recognize sUA and stop its autoinhibition, functions that
hNaip is unable to perform. With the deletion of the
uricase gene in the great apes19, throughout evolution,
mutations affecting hNaip surface electrostatics were
probably selected to increase its physiological tolerance to
high levels of sUA such that the activation of inflamma-
somes is prevented, allowing the great apes to benefit
from the survival advantages provided by high levels of
serum UA21.
Discussion
Among all mNaip proteins, Naip1 presents the highest
amino acid content similarity with hNaip, ~70%. It is pos-
sible that the 30% difference between human and murine
proteins is associated with sUA signalling. In addition,
it has been demonstrated that Naip/Nlrc4 inflammasome
Fig. 5 Structural analysis of the inactive conformations of hNaip and mNaip1, modelled by homology using an inactive form of
Nlrc4 structure (PDB 4KXF) as a template. A Cartoon representation of a mNaip1 (Uniprot: Q9QWK5) homology model. The distinct colours
represent functional regions commonly found in proteins of the NLR family (NBD-HD1-WHD-HD2-LRR), coloured as shown in Zhang et al.57. Clusters
of uric acid (URC) molecules are shown as black meshes, which represent points on the Naip surface where two or more URC were found to bind, in
multiple independent rigid docking simulations. The pose with the lowest ΔG is shown as a yellow sphere representation. B Surface electrostatic
potential calculated for mNaip1. Its solvent-accessible surface is shown with a potential gradient ranging from <−4 kBT (red) to >4 kBT (blue). Yellow
arrows highlight URC clusters shown in panel (A). C A 180° rotation of mNaip1 around its Y-axis. D Cartoon representation of a hNaip (Uniprot:
Q13075) homology model. E Its surface electrostatic potential. F A 180° rotation of hNaip around its Y-axis. See legend for more details.
Braga et al. Cell Death and Disease          (2021) 12:158 Page 11 of 14
Official journal of the Cell Death Differentiation Association
activation is sufficient to cause systemic inflammatory dis-
ease with surprising tibiotarsal joint swelling59, the main
joint affected by gout, a disease triggered by the accumula-
tion of UA60. This is the first study to postulate that Naip
recognizes a DAMP. Our previous work suggested that sUA
activates the Nlrp3 inflammasome16; hence, we also inves-
tigated the role of Nlrp3 in mNaip1-expressing cells. LPS-
primed human THP1 cells produce only the mature form of
IL-1β upon sUA stimulation when they also express Nlrp3
and mNaip1. Most inflammasomes are believed to include
only a single NLR, although other NLR-NLR interactions
have been proposed. The interplay between Nlrp3 and Nlrc4
reveals an unexpected overlap between inflammasome
scaffolds previously thought to be distinct61. In addition, it
was reported that Nlrc4 can recruit Nlrp3 through its
NACHT domain in the context of Salmonella typhimurium
infection61. Hence, in addition to the mechanisms by which
sUA activates the mNaip1 inflammasome, it remains to be
determined whether mNaip1 interacts with Nlrp3 after sUA
stimulation, as we observed no clear evidence of Nlrp3 and
mNaip1 protein interactions.
In addition to responding to PAMPs and DAMPs, the
immune system acts as a signal integrator able to detect
disturbances in the cytoplasm related to metabolites, as
indicated by recent data. These monitored disruptions are
termed “homeostasis-altering molecular processes”62. It
has been shown that Nlrp3 inflammasome complex acti-
vation and posterior caspase-1 and IL-1β production
occur following saturated fatty acid palmitate triggering,
even in human cells63,64. Both QCM and SPR methodol-
ogies indicate that the three-dimensional structure of
mNaip1 provides a great accessible area for interaction
with sUA and no accessible area for interaction with
palmitate. Homology modelling and molecular docking
analysis indicate that the surface electrostatics of mNaip1
enable it to recognize sUA by abolishing its autoinhibition
state, a function that hNaip is unable to perform.
Although we have demonstrated that sUA, but not pal-
mitate, is responsible by directly binds to mNaip1, our
data pointed to increased IL-1β production in the context
of Naip1 expression in human cells following palmitate
stimulation. Therefore, further analyses are necessary to
better investigate the mechanisms by which palmitate can
lead to Naip1 permissiveness to sUA.
In addition, the transcriptome and cellular metabolite
contents were changed in cells upon sUA stimulation, and
the presence of mNaip1 altered some metabolism-related
enzymes and favoured an increase in immune responses
towards sUA. Moreover, we observed that mitochondrial
activity was inhibited in mNaip1-expressing cells stimu-
lated with sUA. This result corroborates the findings of a
study demonstrating that the percentage of TMRE+ cells
was significantly lower in LPS-primed macrophages sti-
mulated with ATP than in control macrophages65.
Uricase activity that is missing because of evolutionary
process endows UA a puzzling history in the evolution of
humans. Great apes have, in the basal state, high phy-
siological levels of sUA, but human macrophages do not
respond to 200 μΜ sUA, an inflammatory-inducing sti-
mulus in murine cells. Uricase inhibition therapy and the
subsequent elevation in serum UA are critical for trig-
gering metabolic syndrome comorbidities in murine
models66–68. We have demonstrated, on the other hand,
that rhesus macaques, a primate with evolutionarily
maintained uricase enzyme activity, have reduced levels of
IL-1β production by their monocyte-derived macrophages
following sUA stimulation. It is possible that rhesus
macaques’ macrophages require higher priming activation
to induce IL-1β transcription since LPS alone did not
increase IL-1β production in these experiments. More-
over, several cytokines, including IL-1β, circulate at very
low levels in both affected and unaffected rhesus maca-
ques in different models of disease69–71. It is also specu-
lated that the rhesus Naip protein was selected because it
tolerates elevated levels of serum UA.
In recent years, an understanding of the additional adverse
effects of high levels of serum UA has advanced72. Early
scientific literature suggested an association between UA
concentration and the incidence of cardiovascular disease;
specifically, the development of hypertension73, metabolic
syndrome74, endothelial dysfunction75 and micro-
albuminuria76. Lifestyle and socioeconomic changes over
time have resulted in a marked reduction in physical activity
and profound dietary changes. These changes correlate with
increased rates of metabolic diseases triggered by overly
active innate immune functions77, with chronic inflamma-
tion termed “metaflammation”78,79. Furthermore, multiple
genetic and non-genetic risk and protective factors are also
thought to contribute to the pathogenesis of metabolic
diseases, specifically those related to hyperuricaemic condi-
tions. Different states of tolerance to sUA sensing by hNaip
may predict the innate immune activation state in the
context of hyperuricaemia-related diseases. These tolerance
differences may be related to polymorphisms in the Naip
gene, changes in the number of gene copies, or even epi-
genetic changes; however, a greater investigation is required.
In this sense, in addition to understanding the human evo-
lutionary process, investigating which mechanisms mediate
the immunomodulatory function of sUA is also essential to
better design rational novel anti-inflammatory therapies.
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